Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Journal of Neuro-Oncology|January 8, 2021
Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluidYutaka Fujioka, Nobuhiro Hata, Yojiro Akagi, et al.World Neurosurgery|December 27, 2021
Changes in the Relapse Pattern and Prognosis of Glioblastoma After Approval of First-Line Bevacizumab: A Single-Center Retrospective StudyYusuke Funakoshi, Kosuke Takigawa, Nobuhiro Hata, et al.Neurologia Medico-Chirurgica|July 9, 2023
Supramaximal Resection Can Prolong the Survival of Patients with Cortical Glioblastoma: A Volumetric StudyRyosuke Otsuji, Nobuhiro Hata, Yusuke Funakoshi, et al.Scientific Reports|October 1, 2020
Base-resolution methylomes of gliomas bearing histone H3.3 mutations reveal a G34 mutant-specific signature shared with bone tumorsYuhei Sangatsuda, Fumihito Miura, Hiromitsu Araki, et al.Journal of Neuro-Oncology|February 6, 2020
First-line bevacizumab contributes to survival improvement in glioblastoma patients complementary to temozolomideNobuhiro Hata, Masahiro Mizoguchi, Daisuke Kuga, et al.Journal of Neuro-Oncology|July 29, 2021
Volumetric study reveals the relationship between outcome and early radiographic response during bevacizumab-containing chemoradiotherapy for unresectable glioblastomaKosuke Takigawa, Nobuhiro Hata, Yuhei Michiwaki, et al.Cancer Medicine|April 10, 2021
Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH-wildtype glioblastomaYusuke Funakoshi, Nobuhiro Hata, Kosuke Takigawa, et al.Cancer & Metabolism|November 20, 2024
Glutaminolysis is associated with mitochondrial pathway activation and can be therapeutically targeted in glioblastomaKenji Miki, Mikako Yagi, Ryusuke Hatae, et al.Frontiers in Immunology|July 16, 2021
CD206 Expression in Induced Microglia-Like Cells From Peripheral Blood as a Surrogate Biomarker for the Specific Immune Microenvironment of Neurosurgical Diseases Including GliomaShunya Tanaka, Masahiro Ohgidani, Nobuhiro Hata, et al.Pathology, Research and Practice|October 2, 2024
All-in-one bimodal DNA and RNA next-generation sequencing panel for integrative diagnosis of gliomaNayuta Higa, Toshiaki Akahane, Mari Kirishima, et al.Pageof 6